ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
0.00%
US Dollar vs MXN
18.51145
0.25%
Brent Oil
82.495
0.45%
Bitcoin
65,740.17
-1.35%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
17/06/202407:06Business WireOQ Chemicals erhält ISCC Plus-Zertifizierung für seinen Standort in Bay City, Texas
17/06/202407:06Business WireWolters Kluwer AI-powered advanced virtual agent ushers in the next generation of customer support
17/06/202407:05Business WireAgilysys Golf, Used by 13 of the Top 20 Resort Courses in the U.S., To Be Demonstrated at HITEC 2024 June 24 -27NASDAQ:AGYSAgilysys Inc
17/06/202407:05PR Newswire (US)BrightStar Care® Receives Prestigious Fast 50 Award from Crain's Chicago Business
17/06/202407:05Business WireDelve Bio Announces Clinical Data on the Use of Metagenomic Next-Generation Sequencing (mNGS) to Identify Pathogens Causing Central Nervous System Infections
17/06/202407:05GlobeNewswire Inc.Inhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s DiseaseNASDAQ:IKTInhibikase Therapeutics Inc
17/06/202407:05PR Newswire (US)Day Zero Diagnostics Presents Direct-From-Blood, Rapid Antimicrobial Susceptibility Testing at ASM Microbe
17/06/202407:05GlobeNewswire Inc.National Tax Practice Institute (NTPI®) Available During Orlando Tax Summit for Enrolled Agents, CPAs, CFPs and Tax Preparers
17/06/202407:05PR Newswire (Canada)SPECSAVERS CHAMPIONS NEXT GENERATION OF OPTOMETRISTS IN CANADA
17/06/202407:05GlobeNewswire Inc.Amwell Announces Appointment of Ricky Goldwasser to its Board of DirectorsNYSE:AMWLAmerican Well Corporation
17/06/202407:05Business WireAlliant Insurance Services’ Employee Benefits Team Welcomes Kevin Wintermute as Executive Vice President
17/06/202407:05PR Newswire (US)Woman-Founded Technology Company, ZENDA, LLC, Adds CTO to Round Out C-Suite of Woman CEO, COO and CTO
17/06/202407:04Edgar (US Regulatory)Form 8-K - Current reportNYSE:DYDycom Industries Inc
17/06/202407:04PR Newswire (US)Yubo Head of Legal & Public Policy Sharone Franco joins Tech Coalition Board of Directors
17/06/202407:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:VALEVale SA
17/06/202407:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:TEVATeva Pharmaceutical Industries Ltd
17/06/202407:03GlobeNewswire Inc.Marex to offer client clearing of interest rate swapsNASDAQ:MRXMarex Group PLC
17/06/202407:03Business WireCure Rare Disease Expands Leadership Team and Board of Directors to Advance Mission
17/06/202407:03PR Newswire (US)Buzz Dealer Set to Make a Splash at iFX Expo International 2024 In Limassol
17/06/202407:02PR Newswire (US)Marine Outboard Engines Market size is set to grow by USD 3.29 billion from 2024-2028, Rising sales of boats boost the market, Technavio
17/06/202407:02PR Newswire (US)FORESIGHT SPORTS AND SPORTSBOX AI INDUSTRY-FIRST LAUNCH MONITOR TECHNOLOGY INTEGRATED WITH 3D MOTION SWING CAPTURE AVAILABLE NOW
17/06/202407:02PR Newswire (US)PSA: Petco Chief Veterinarian Offers Summer Safety Tips
17/06/202407:01PR Newswire (US)China's highest procuratorial organ brings legal experts to college campuses
17/06/202407:01PR Newswire (US)Neuromod's FDA-Approved Lenire Device Now a Treatment Option for 2.9 Million US Veterans with Tinnitus
17/06/202407:01PR Newswire (Canada)Awiqli® - world's first once-weekly basal insulin - now available in Canada
17/06/202407:01PR Newswire (Canada)Awiqli® - la première insuline basale à prise hebdomadaire au monde - maintenant disponible au Canada
17/06/202407:01PR Newswire (US)PMB partners with Riverside University Health System on a $580 million behavioral health campus in Mead Valley, California
17/06/202407:01PR Newswire (US)Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
17/06/202407:01PR Newswire (US)Almond Board of California Announces 2024 Tastemaker Trials Student Competition Winners
17/06/202407:01GlobeNewswire Inc.Elutia Announces $13.26 Million Registered Direct OfferingNASDAQ:ELUTElutia Inc

Su Consulta Reciente

BOV
PAGS34M
PagSeguro Digital
AQSE
SWRD.GB
SPDR MSCI WORLD UCITS ETF
BIT
WSGC27
SG
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados